Patient-reported outcomes from a phase HI multicenter, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing alter chemotherapy: Cancer Oesophagus Gefitinib (COG)

Схожие документы

• Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
  по: Dutton, S, и др.
  Опубликовано: (2014)
• Gefitinib and Epidermal Growth Factor Receptor Gene Copy Number Aberrations in Esophageal Cancer
  по: Petty, R, и др.
  Опубликовано: (2017)
• Gefitinib and EGFR gene copy number aberrations in esophageal cancer
  по: Petty, RD, и др.
  Опубликовано: (2017)
• Busting the Breast Cancer with AstraZeneca’s Gefitinib
  по: S. Chemmalar, и др.
  Опубликовано: (2023-01-01)
• Glycyrol Alone or in Combination with Gefitinib Is Effective against Gefitinib-Resistant HCC827GR Lung Cancer Cells
  по: Shuang Zhao, и др.
  Опубликовано: (2021-11-01)